XGEN PHARMS FDA Approval ANDA 063000

ANDA 063000

XGEN PHARMS

FDA Drug Application

Application #063000

Application Sponsors

ANDA 063000XGEN PHARMS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 500,000 UNITS BASE/VIAL0POLYMYXIN B SULFATEPOLYMYXIN B SULFATE

FDA Submissions

ORIG1AP1994-09-30
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1996-02-20
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1998-01-16
LABELING; LabelingSUPPL5AP1998-01-16
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1999-11-24
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2001-11-13

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL4Null0
SUPPL6Null0
SUPPL7Null0

TE Codes

001PrescriptionAP

CDER Filings

XGEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 63000
            [companyName] => XGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"POLYMYXIN B SULFATE","activeIngredients":"POLYMYXIN B SULFATE","strength":"EQ 500,000 UNITS BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"POLYMYXIN B SULFATE","submission":"POLYMYXIN B SULFATE","actionType":"EQ 500,000 UNITS BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.